Status and phase
Conditions
Treatments
About
This study will evaluate the safety and tolerability of increasing doses of PF-06840003 in patients with malignant gliomas.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
17 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal